ISRG vs BSX
ISRG and BSX side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ISRGIntuitive Surgical, Inc. | BSXBOSTON SCIENTIFIC CORP |
|---|---|---|
| Market cap | $122.33B | $65.43B |
| P/E (TTM) | 42.0 | 18.4 |
| P/B | 7.00 | 2.53 |
| P/S | 12.2x | 3.3x |
| Revenue | $10.58B(TTM) | $20.61B(TTM) |
| Revenue growth (YoY) | 20.5% | 19.9% |
| Net income | $2.98B(TTM) | — |
| Earnings growth (YoY) | 23.0% | — |
| EPS, diluted | $8.23(TTM) | $2.39(TTM) |
| EBIT margin | 29.3% | 18.0% |
| ROE | 16.3% | 0.0% |
| ROIC | — | 10.5% |
| 1y total return | -33.1% | -57.9% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: ISRG frente a BSX
| Métrica | ISRG | BSX |
|---|---|---|
| Valor final | $52.9K | $24.6K |
| Retorno total | +429.2% | +145.8% |
| CAGR | +17.5% | +9.1% |
| Volatilidad | 32.5% | 27.3% |
| Sharpe | 0.54 | 0.32 |
| Sortino | 0.78 | 0.43 |
| Caída máxima | -49.9% | -60.6% |
Basado en 2600 días de negociación comunes, 2016-03-15 → 2026-07-17 · tasa libre de riesgo 3.85% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)